These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 25058877)

  • 1. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of skin sensitizers using alternative methods to animal experimentation.
    Johansson H; Lindstedt M
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):110-7. PubMed ID: 24548737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies.
    Piersma AH; Burgdorf T; Louekari K; Desprez B; Taalman R; Landsiedel R; Barroso J; Rogiers V; Eskes C; Oelgeschläger M; Whelan M; Braeuning A; Vinggaard AM; Kienhuis A; van Benthem J; Ezendam J
    Toxicol In Vitro; 2018 Aug; 50():62-74. PubMed ID: 29501630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
    Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
    Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
    Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.
    Scholz S; Sela E; Blaha L; Braunbeck T; Galay-Burgos M; García-Franco M; Guinea J; Klüver N; Schirmer K; Tanneberger K; Tobor-Kapłon M; Witters H; Belanger S; Benfenati E; Creton S; Cronin MT; Eggen RI; Embry M; Ekman D; Gourmelon A; Halder M; Hardy B; Hartung T; Hubesch B; Jungmann D; Lampi MA; Lee L; Léonard M; Küster E; Lillicrap A; Luckenbach T; Murk AJ; Navas JM; Peijnenburg W; Repetto G; Salinas E; Schüürmann G; Spielmann H; Tollefsen KE; Walter-Rohde S; Whale G; Wheeler JR; Winter MJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):506-30. PubMed ID: 24161465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.
    Basketter D; Alépée N; Casati S; Crozier J; Eigler D; Griem P; Hubesch B; de Knecht J; Landsiedel R; Louekari K; Manou I; Maxwell G; Mehling A; Netzeva T; Petry T; Rossi LH
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):531-5. PubMed ID: 24140884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?].
    Lilienblum W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.
    Embry MR; Belanger SE; Braunbeck TA; Galay-Burgos M; Halder M; Hinton DE; Léonard MA; Lillicrap A; Norberg-King T; Whale G
    Aquat Toxicol; 2010 Apr; 97(2):79-87. PubMed ID: 20061034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methods for ocular toxicology testing: validation, applications and troubleshooting.
    Dholakiya SL; Barile FA
    Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):699-712. PubMed ID: 23527818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes.
    Gissi A; Gadaleta D; Floris M; Olla S; Carotti A; Novellino E; Benfenati E; Nicolotti O
    ALTEX; 2014; 31(1):23-36. PubMed ID: 24247988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REACH, non-testing approaches and the urgent need for a change in mind set.
    Schaafsma G; Kroese ED; Tielemans EL; Van de Sandt JJ; Van Leeuwen CJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):70-80. PubMed ID: 19061930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M; Lidbury BA; Yang C; Hayden PJ; Kelm JM; Ringeissen S; Detroyer A; Meunier JR; Rathman JF; Jackson GR; Stolper G; Hasiwa N
    ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.